Envista Holdings Corporation (NYSE:NVST – Get Free Report) SVP Mischa Reis sold 8,000 shares of Envista stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $27.50, for a total transaction of $220,000.00. Following the completion of the transaction, the senior vice president directly owned 27,321 shares in the company, valued at approximately $751,327.50. The trade was a 22.65% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Envista Trading Up 0.6%
Shares of NYSE:NVST opened at $27.52 on Wednesday. The company’s 50-day moving average price is $27.00 and its two-hundred day moving average price is $26.36. Envista Holdings Corporation has a one year low of $18.77 and a one year high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07. The stock has a market capitalization of $4.42 billion, a PE ratio of 47.44, a price-to-earnings-growth ratio of 1.30 and a beta of 0.86.
Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.07. The company had revenue of $730.50 million during the quarter, compared to analysts’ expectations of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.Envista’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, equities analysts forecast that Envista Holdings Corporation will post 1.53 EPS for the current fiscal year.
Institutional Trading of Envista
Wall Street Analyst Weigh In
NVST has been the topic of several recent analyst reports. Barclays lowered their price target on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a research report on Thursday, June 11th. Zacks Research raised shares of Envista from a “hold” rating to a “strong-buy” rating in a research note on Friday, August 7th. BMO Capital Markets began coverage on shares of Envista in a report on Wednesday, July 8th. They set a “market perform” rating and a $27.00 target price on the stock. Robert W. Baird set a $34.00 price target on shares of Envista in a research report on Thursday, August 6th. Finally, Wall Street Zen upgraded shares of Envista from a “buy” rating to a “strong-buy” rating in a research note on Saturday. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $29.31.
Read Our Latest Report on Envista
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Featured Articles
- Five stocks we like better than Envista
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
